SavedAdd your journal

Journals / Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi / 2020 / Cilt: 11 - Sayı: 2

Design and Analysis Of Recombinant Vaccine Against Clostridium Perfringens Type A and Type E

Clostridium Perfringens Tip A ve Tip E'ye Karşı Rekombinant Aşı Tasarımı ve Analizi

Mostafa NORİZADEHTAZEKHAND
Pages
138–143
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The instability index of vaccinewas 28.41 (

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Clostridium perfringens (C. perfringens) is aspore-forming, anaerobic, gram positive, bacteria that foundin environment, soils, foods, and in intestinal traces of humansor animals.
📊
Key Findings & Data:However, vaccines being developed for use inanimals have the potential to be developed for use in humans.This study was aimed to design and analysis of multi epitopevaccine against C. perfringens type A and E.Material-Method: The B cell epitopes were predicted byIEDB (https://www.iedb.org/) and MCH Class II epitopeswere predicted by Vaxign 2 Beta (http://www.violinet.org/vaxign/) and Propred-I 2003 (http://crdd.osdd.net/raghava/propred1/) web server.Results: Physicochemical study of vaccine showed that thedesigned vaccine is 58.33 kDa.
💡
Conclusion & Impact:The instability index of vaccinewas 28.41 (
🔬Design:Research Article
📍Scope:2003 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Clostridium perfringens (C. perfringens) is aspore-forming, anaerobic, gram positive, bacteria that foundin environment, soils, foods, and in intestinal traces of humansor animals. However, vaccines being developed for use inanimals have the potential to be developed for use in humans.This study was aimed to design and analysis of multi epitopevaccine against C. perfringens type A and E.Material-Method: The B cell epitopes were predicted byIEDB (https://www.iedb.org/) and MCH Class II epitopeswere predicted by Vaxign 2 Beta (http://www.violinet.org/vaxign/) and Propred-I 2003 (http://crdd.osdd.net/raghava/propred1/) web server.Results: Physicochemical study of vaccine showed that thedesigned vaccine is 58.33 kDa. The half-life of candidatevaccine was found to be greater than 100 hours in mammaliancells, greater than 20 hours in yeast, and greater than 10hours in Escherichia coli. The instability index of vaccinewas 28.41 (

Özet

Amaç: Clostridium perfringens (C. perfringens), çevrede, topraklarda, gıdalarda ve insanların veya hayvanların bağırsaklarında bulunabilen ve spor oluşturan, anaerobik ve gram pozitif bakteridir. Hayvanlarda kullanmak için geliştirilen aşılar insanlar tarafından da kullanma potansiyeline sahip olabilir. Bu çalışmada, C. perfringens tip A ve E'ye karşı çoklu epitop aşısının tasarlanması ve analizi amaçlanmıştır. Materyal-Metot: B hücresi epitopları IEDB (https://www. iedb.org/) ve MCH Class II epitopları ise Vaxign 2 Beta (http://www.violinet.org/vaxign/) ve Propred-I 2003 (http:// crdd.osdd.net/raghava/propred1/) programın kullanarak tasarlanmıştır. Bulgular: Elde edilen fizikokimyasal sonuçlara göre tasarlanan aşı 58,33 kDa ağırlığına sahip olmaktadır. Aday aşının yarılanma ömrü memeli hücrelerinde 100 saatin üzerinde, mayada 20 saatin üzerinde ve Escherichia coli'de 10 saatin üzerinde olduğu bulunmuştur. Aşının instabilite indeksi 28,41 (

🔖

Cite This Article

NORİZADEHTAZEKHAND, M. (2022). Design and Analysis Of Recombinant Vaccine Against Clostridium Perfringens Type A and Type E. Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi, Cilt: 11 - Sayı: 2, 138–143. https://ajindex.com/articles/594286

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. McClane B, Uzal F, Miyakawa M, Lyerly D, Wilkins T. The Enterotoxic 644 Clostridia. 2006
  2. Li J, Adams V, Bannam TL, Miyamoto K, Garcia JP, Uzal FA, et al. Toxin plasmids of Clostridium perfringens. Microbiol Mol Biol Rev. 2013;77(2):208-33
  3. Awad MM, Bryant AE, Stevens DL, Rood JI. Virulence studies on chromosomal α‐toxin and Θ‐toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of α‐toxin in Clostridium perfringensmediated gas gangrene. Molecular microbiology. 1995;15(2):191-202
  4. Fernández Miyakawa ME, Uzal FA. Morphologic and physiologic changes induced by Clostridium perfringens type A α toxin in the intestine of sheep. American journal of veterinary research. 2005;66(2):251-5
  5. Songer JG. Clostridial diseases of small ruminants. 1998
  6. Bryant AE, Chen RY, Nagata Y, Wang Y, Lee C, Finegold S, et al. Clostridial Gas Gangrene. I. Cellular and Molecular Mechanisms of Microvascular Dysfunction Induced by Exotoxins of Clostvidium pevfvingens. The Journal of infectious diseases. 2000;182(3):799-807
  7. Naylor CE, Eaton JT, Howells A, Justin N, Moss DS, Titball RW, et al. Structure of the key toxin in gas gangrene. Nature Structural & Molecular Biology. 1998;5(8):738
  8. Sakurai J, Nagahama M, Oda M. Clostridium perfringens alpha-toxin: characterization and mode of action. Journal of biochemistry. 2004;136(5):569-74
  9. Nagahama M, Yamaguchi A, Hagiyama T, Ohkubo N, Kobayashi K, Sakurai J. Binding and internalization of Clostridium perfringens iota-toxin in lipid rafts. Infection and immunity. 2004;72(6):3267-75
  10. Richard JF, Mainguy G, Gibert M, Marvaud JC, Stiles BG, Popoff MR. Transcytosis of iota‐toxin across polarized CaCo‐2 cells. Molecular microbiology. 2002;43(4):907-17
  11. Redondo LM, Carrasco JMD, Redondo EA, Delgado F, Miyakawa MEF. Clostridium perfringens type E virulence traits involved in gut colonization. PloS one. 2015;10(3):e0121305
  12. Dikhit MR, Kumar A, Das S, Dehury B, Rout AK, Jamal F, et al. Identification of potential MHC Class-II-restricted epitopes derived from Leishmania donovani antigens by reverse vaccinology and evaluation of their CD4+ T-cell responsiveness against visceral leishmaniasis. Frontiers in immunology. 2017;8:1763
  13. Doyle MP, Buchanan RL. Food microbiology: fundamentals and frontiers: American Society for Microbiology Press; 2012
  14. Dimitrov I, Bangov I, Flower DR, Doytchinova I. AllerTOP v. 2—a server for in silico prediction of allergens. Journal of m